Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TC-5214 in Palmar Hyperhidrosis
NCT03404570Phase 2Completed
- Sponsor
- Atacama Therapeutics, Inc.
- Start
- Dec 2017
- Primary completion
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dexmecamylamine in palmar hyperhidrosis (PH), sponsored by Atacama Therapeutics, Inc.. Started Dec 2017; status: completed.
02
Drugs
dexmecamylamine
03
Conditions
palmar hyperhidrosis (PH)
Beyond the preview
Go deeper on NCT03404570.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03404570.